Key result
Atrial fibrillation was associated with a significant increase in plasma trimethylamine N-oxide and fecal zonulin levels compared to healthy controls.
Why the study?
The study aimed to compare fecal zonulin and plasma trimethylamine N-oxide profiles between healthy volunteers and patients with atrial fibrillation to understand their clinical and nosological determinants.
Do fecal zonulin and plasma TMAO levels differ between patients with atrial fibrillation and healthy volunteers?
Cross-Sectional (n=163)
No
Do fecal zonulin and plasma TMAO levels differ between patients with atrial fibrillation and healthy volunteers?
Fecal zonulin and plasma TMAO are significantly elevated in patients with atrial fibrillation and correlate with arrhythmia duration and severity, suggesting a link between intestinal barrier dysfunction, microbial metabolites, and low-grade inflammation in AF.
Answers are grounded in this paper and cite their sources.
AF-associated TMAO and zonulin elevations should not change practice; hypothesis-generating for gut permeability in AF and needs prospective validation.
Aim. To compare fecal zonulin and plasma trimethylamine N-oxide (TMAO) profiles in healthy volunteers and patients with atrial fibrillation (AF). Material and methods. The comparative study involved 163 participants, divided into two following groups: 48 healthy individuals and 113 patients with AF. The groups were comparable by age characteristics (KS p>0,05; 37 to 60 years, Me =46, 41,8-53,3; 40 to 59 years, Me =49, 43-53, respectively). There was the following sex distribution among groups (Chi-squared p<0,05): 81% women and 19% men in the healthy study group and 49,6% and 50,4% in the AF group, respectively. Results. Patients with AF were associated with higher plasma TMAO levels (KS p<0,05) compared to healthy controls (Me =5,2, 4,4-6,4 μmol/L and Me =2,7, 2,4-3,2 μmol/L, respectively). Zonulin distribution was similar between the two groups (KS p<0,05; Me =111,5, 101,8-124 ng/ml and Me =50,4, 46,6-67,6 ng/ml, respectively). AF was associated with a 1,1 μmol/L increase in TMAO, with the greatest contribution from long-term persistent AF (+1,79 μmol/L). TMAO levels were further increased by EHRA III (+1,78 μmol/L), hypertension (+0,86 μmol/L), and heart failure (+0,80 μmol/L). For zonulin, AF led to a 35,9 ng/mL increase, with a gradient increase from paroxysmal AF (+6,4 ng/mL) to long-standing persistent AF (+22,8 ng/mL). Severe AF symptoms (EHRA III: +30,2 ng/mL) and hypertension (+7,7 ng/mL) contributed significantly, while the heart failure effect was minimal (+1,2 ng/mL). Conclusion. Fecal zonulin and plasma TMAO in patients with AF can be used as markers of low-grade inflammation associated with intestinal wall condition.
No takes yet. Share an insight, caveat, or question.
Горбенко et al. (2026) conducted a cross-sectional in Atrial fibrillation (n=163). Atrial fibrillation vs. Healthy individuals was evaluated on Plasma trimethylamine N-oxide (TMAO) level (MD 1.1, p=<0.05). Atrial fibrillation was associated with a significant increase in plasma trimethylamine N-oxide and fecal zonulin levels compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: